Announcements Trials
Browse Landscape

Phase

Phase 3 41Phase 2 37Phase 4 28Phase 1 11Phase NA 7Phase 1/2 4Phase 2/3 3

Status

Completed 3Unknown 2Active not recruiting 1

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 2Genitourinary 1

Conditions

Prostatic Neoplasms 1Metastatic Breast Cancer With Bone Involvement 1Insulin Resistance 1Breast Neoplasms 1

Interventions

Cisplatin 22Fluorouracil 21Radiotherapy 18Gemcitabine 17Docetaxel 16Oxaliplatin 15Paclitaxel 14Carboplatin 13Capecitabine 13Bevacizumab 13Leucovorin 11Cyclophosphamide 11Irinotecan 10Drug Therapy 10Cytarabine 9Saline Solution 7Magnetic Resonance Spectroscopy 7Letrozole 7Dexamethasone 7Rituximab 6Nivolumab 6Methotrexate 6Exercise 6Etoposide 6Electroporation 6Doxorubicin 6pembrolizumab 5Pemetrexed 5Metformin 5Melphalan 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2/3 × Completed × Zoledronic Acid × Clear all
NCT01006395 2019-07-05

Prevention of Micro-architectural Bone Decay in Males With Non-metastatic Prostate Cancer Receiving Androgen Deprivation Therapy (ADT)

Austin Health

Phase 2/3 Completed
64 enrolled
Genitourinary

Insulin Resistance, Prostatic Neoplasms

NCT01344967 2015-06-23

SuBDuE

University Health Network, Toronto

Phase 2/3 Completed
21 enrolled
Breast

Metastatic Breast Cancer With Bone Involvement

NCT00524849 2010-09-14

Zometa and Circulating Vascular Endothelial Growth Factor (VEGF) in Breast Cancer Patients With Bone Metastasis

Fudan University

Phase 2/3 Completed
60 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡